IB-MS decreases disability progression in patients with progressive forms of multiple sclerosis. A double blind placebo controlled study

Authors
Category Primary study
JournalMultiple Sclerosis
Year 2016
This article has no abstract
Epistemonikos ID: d8f64925f1ff46d01c5880554988d5ced2bc41cc
First added on: Feb 07, 2025